EP3823670A4 - Procédés pour une détection et une différenciation combinées d'une infection par un complexe de mycobacterium tuberculosis et par des mycobactéries non tuberculeuses - Google Patents

Procédés pour une détection et une différenciation combinées d'une infection par un complexe de mycobacterium tuberculosis et par des mycobactéries non tuberculeuses Download PDF

Info

Publication number
EP3823670A4
EP3823670A4 EP19837872.1A EP19837872A EP3823670A4 EP 3823670 A4 EP3823670 A4 EP 3823670A4 EP 19837872 A EP19837872 A EP 19837872A EP 3823670 A4 EP3823670 A4 EP 3823670A4
Authority
EP
European Patent Office
Prior art keywords
differentiation
infection
methods
tuberculosis
combined detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19837872.1A
Other languages
German (de)
English (en)
Other versions
EP3823670A1 (fr
Inventor
Abraham Pinter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rutgers State University of New Jersey
Original Assignee
Rutgers State University of New Jersey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rutgers State University of New Jersey filed Critical Rutgers State University of New Jersey
Publication of EP3823670A1 publication Critical patent/EP3823670A1/fr
Publication of EP3823670A4 publication Critical patent/EP3823670A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1289—Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/35—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycobacteriaceae (F)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Optics & Photonics (AREA)
  • Peptides Or Proteins (AREA)
EP19837872.1A 2018-07-19 2019-07-18 Procédés pour une détection et une différenciation combinées d'une infection par un complexe de mycobacterium tuberculosis et par des mycobactéries non tuberculeuses Withdrawn EP3823670A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862700608P 2018-07-19 2018-07-19
PCT/US2019/042424 WO2020018806A1 (fr) 2018-07-19 2019-07-18 Procédés pour une détection et une différenciation combinées d'une infection par un complexe de mycobacterium tuberculosis et par des mycobactéries non tuberculeuses

Publications (2)

Publication Number Publication Date
EP3823670A1 EP3823670A1 (fr) 2021-05-26
EP3823670A4 true EP3823670A4 (fr) 2022-04-20

Family

ID=69164829

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19837872.1A Withdrawn EP3823670A4 (fr) 2018-07-19 2019-07-18 Procédés pour une détection et une différenciation combinées d'une infection par un complexe de mycobacterium tuberculosis et par des mycobactéries non tuberculeuses

Country Status (3)

Country Link
US (1) US20210302424A1 (fr)
EP (1) EP3823670A4 (fr)
WO (1) WO2020018806A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7130045B2 (ja) * 2018-08-31 2022-09-02 富士フイルム株式会社 イムノクロマトグラフキットおよび結核菌の検出方法
WO2021127096A1 (fr) * 2019-12-17 2021-06-24 National Jewish Health Méthodes de détection de lipoarabinomannane et de diagnostic d'infection mycobactérienne non tuberculeuse
CN116381231B (zh) * 2023-04-06 2025-09-26 首都医科大学附属北京胸科医院 检测分枝杆菌脂阿拉伯甘露聚糖的抗体组合及其应用和试剂盒

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130309237A1 (en) * 2011-01-24 2013-11-21 Dso National Laboratories Pathogenic Mycobacteria-Derived Mannose-Capped Lipoarabinomannan Antigen Binding Proteins
WO2017139153A1 (fr) * 2016-02-10 2017-08-17 Rutgers, The State University Of New Jersey Nouveaux anticorps monoclonaux anti-lam et anti-pim6/lam pour le diagnostic et le traitement d'infections par le bacille de koch
EP3845903A1 (fr) * 2018-08-31 2021-07-07 FUJIFILM Corporation Kit d'immunochromatographie et méthode de détection de mycobacterium tuberculosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005026665D1 (de) * 2004-07-20 2011-04-14 Chemogen Inc Angereicherter antikörper zur detektion von mikrobakterieller infektion, verfahren zur anwendung und diagnosetest damit

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130309237A1 (en) * 2011-01-24 2013-11-21 Dso National Laboratories Pathogenic Mycobacteria-Derived Mannose-Capped Lipoarabinomannan Antigen Binding Proteins
WO2017139153A1 (fr) * 2016-02-10 2017-08-17 Rutgers, The State University Of New Jersey Nouveaux anticorps monoclonaux anti-lam et anti-pim6/lam pour le diagnostic et le traitement d'infections par le bacille de koch
EP3845903A1 (fr) * 2018-08-31 2021-07-07 FUJIFILM Corporation Kit d'immunochromatographie et méthode de détection de mycobacterium tuberculosis

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ALOK CHOUDHARY ET AL: "Characterization of the Antigenic Heterogeneity of Lipoarabinomannan, the Major Surface Glycolipid of Mycobacterium tuberculosis , and Complexity of Antibody Specificities toward This Antigen", THE JOURNAL OF IMMUNOLOGY, vol. 200, no. 9, 2 April 2018 (2018-04-02), US, pages 3053 - 3066, XP055621331, ISSN: 0022-1767, DOI: 10.4049/jimmunol.1701673 *
CHAN CONRAD E. ET AL: "The diagnostic targeting of a carbohydrate virulence factor from M.Tuberculosis", SCIENTIFIC REPORTS, 15 May 2015 (2015-05-15), XP055901197, Retrieved from the Internet <URL:http://www.nature.com/articles/srep10281.pdf> [retrieved on 20220315], DOI: 10.1038/srep10281 *
CONRAD E. CHAN ET AL: "The diagnostic targeting of a carbohydrate virulence factor from M.Tuberculosis_Supplementary information", SCIENTIFIC REPORTS, vol. 5, no. 1, 15 May 2015 (2015-05-15), XP055621851, DOI: 10.1038/srep10281 *
See also references of WO2020018806A1 *
SIGAL GEORGE B ET AL: "A Novel Sensitive Immunoassay Targeting the 5-Methylthio-DXylofuranose-Lipoarabinomannan Epitope Meets the WHO's Performance Target for Tuberculosis Diagnosis", JOURNAL OF CLINICAL MICROBIOLOGY, VOLUME 56, ISSUE 12, E01338-18, 1 December 2018 (2018-12-01), XP093247472, Retrieved from the Internet <URL:https://journals.asm.org/doi/epub/10.1128/jcm.01338-18> [retrieved on 20220220] *

Also Published As

Publication number Publication date
WO2020018806A1 (fr) 2020-01-23
EP3823670A1 (fr) 2021-05-26
US20210302424A1 (en) 2021-09-30

Similar Documents

Publication Publication Date Title
EP3874030A4 (fr) Compositions et procédés pour l&#39;ingénierie des lymphocytes t
EP3765608A4 (fr) Compositions de régulation génique et procédés pour améliorer l&#39;immunothérapie
EP3740217A4 (fr) Procédés d&#39;utilisation pour des lymphocytes t car
EP3765092A4 (fr) Compositions de régulation génique et procédés pour améliorer l&#39;immunothérapie
EP3765094A4 (fr) Compositions de régulation génique et procédés pour améliorer l&#39;immunothérapie
EP3510171A4 (fr) Compositions et procédés pour la détection de mutations d&#39;acides nucléiques
MA44658A (fr) Procédés et kits de diagnostic et de stratification des risques de patients souffrant d&#39;ischémie
EP3820488A4 (fr) Cibles géniques pour immunothérapie à base de lymphocytes t
MA50636A (fr) Compositions et procédés pour inhiber l&#39;activité d&#39;arginase
EP2716766A4 (fr) Kits, dispositifs et procédés pour détecter le nombre de copies chromosomiques d&#39;un embryon ou d&#39;une tumeur
EP3931351A4 (fr) Systèmes, compositions, et procédés pour la détection d&#39;entités cible
MA47208A (fr) Procédés de traitement du cancer à l&#39;aide d&#39;anticorps anti-pd-1
EP3806902A4 (fr) Compositions et procédés pour prévenir ou inverser l&#39;épuisement des lymphocytes t par cytose cible médiée par des anticorps inhibant les ectonucléotidases
EP3823670A4 (fr) Procédés pour une détection et une différenciation combinées d&#39;une infection par un complexe de mycobacterium tuberculosis et par des mycobactéries non tuberculeuses
ZA201805990B (en) Novel anti-lam and anti-pim6/lam monoclonal antibodies for diagnosis and treatment of mycobacterium tuberculosis infections
EP3302507A4 (fr) Procédés de diagnostic pour thérapie par lymphocytes t
MA37681A2 (fr) Procédés pour modifier des lymphocytes t résistants allogéniques et immunosuppresseurs pour l&#39;immunothérapie
EP3310395A4 (fr) Régulation de la transcription à guidage arn et procédés d&#39;utilisation de celle-ci pour le traitement des lombalgies
EP3867397A4 (fr) Procédés et réactifs pour le génotypage efficace de grands nombres d&#39;échantillons par regroupement
MA49246A (fr) Procédés de prédiction de l&#39;utilité de modifications d&#39;acides aminés spécifiques d&#39;une maladie pour l&#39;immunothérapie
EP3768281A4 (fr) Compositions et procédés d&#39;activation de lymphocytes t et de cytokines
MA43372A (fr) Compositions à greffe de cytokine-anticorps et procédés d&#39;utilisation pour l&#39;immunorégulation
EP3793562A4 (fr) Procédés et compositions pour inhiber la dihydroorotate déshydrogénase
EP3283128A4 (fr) Procédés de transmétallation pour la synthèse d&#39;agents d&#39;imagerie par spect et pet
EP3897717A4 (fr) Procédés de production d&#39;anticorps hétérodimères

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210217

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0039400000

Ipc: G01N0033569000

A4 Supplementary search report drawn up and despatched

Effective date: 20220323

RIC1 Information provided on ipc code assigned before grant

Ipc: C07K 16/12 20060101ALI20220318BHEP

Ipc: A61P 31/06 20060101ALI20220318BHEP

Ipc: A61K 39/04 20060101ALI20220318BHEP

Ipc: G01N 33/569 20060101AFI20220318BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20250213

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20251125